Clinical Trial Update: Metformin Versus Myo-inositol in the Management of Polycystic Ovarian Disease: A Comparative Study [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial comparing metformin versus myo-inositol for the management of Polycystic Ovary Syndrome is currently not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Polycystic Ovary Syndrome

Drugs mentioned

• Myo-inositol (myo-inositol)
• metformin (metformin)

Snippet

Sponsor: Fatima Tariq | Conditions: Polycystic Ovarian Syndrome (PCOS) | Phase 1 | Status: NOT_YET_RECRUITING